Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
about
Progress toward curing HIV infection with hematopoietic cell transplantationAlternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaComplement fragment 3a priming of umbilical cord blood progenitors: safety profile.Engineering cord blood to improve engraftment after cord blood transplant.Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignanciesUmbilical cord blood transplantation: the first 25 years and beyond.Cutaneous lymphocyte antigen expression loss and PD1 positivity in early cutaneous lesions of rapidly progressive mycosis fungoides.Blood and marrow transplant clinical trials network state of the Science Symposium 2014Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilizationEngraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen.Hematopoietic cell transplantation with cord blood for cure of HIV infections.In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignanciesUmbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.CD34(+) expansion with Delta-1 and HOXB4 promotes rapid engraftment and transfusion independence in a Macaca nemestrina cord blood transplant modelCord blood transplantation for cure of HIV infectionsReduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantationBackground and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.CCR5 as a natural and modulated target for inhibition of HIV.Allogeneic stem cell transplantation for myelofibrosis in 2012.Emerging concepts in haematopoietic cell transplantation.Cord Blood Transplantation: Can We Make it Better?Improving engraftment and immune reconstitution in umbilical cord blood transplantation.Haploidentical stem cell transplantation for the treatment of leukemia: current status.Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?Cell therapies for treatment of human immunodeficiency virus infection.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task.Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.Impact of T cells on hematopoietic stem and progenitor cell function: Good guys or bad guys?TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.Human cord blood applications in cell therapy: looking back and look ahead.Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaSevere infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).
P2860
Q26801269-7D350D28-F9E0-421D-87D7-C2A0EB5647D3Q28080943-82A73AB7-BE2E-4704-A0DC-537786FF1522Q30366297-659AD37F-1743-4BB7-B4F5-74C00D20A91BQ33766995-DCAC6E60-4A87-44F8-85BB-A58D1F5F0CFEQ33978945-F090A435-5D1C-4539-87ED-01BB9C092740Q33985578-E22CE279-F7D4-4BE1-8E10-E0A07E7EF0A3Q34175568-9284827E-D482-43F3-B338-7B52E2F8B9FAQ34344669-2725D7D8-30AF-4CE1-8136-0CA8152523FCQ34998305-31558F9F-967E-481F-8E78-10F4D3DF7079Q35591760-F01430C2-F9C5-4FA0-A1C7-97AD2C152E65Q35845470-7F61D017-54D9-49DF-AC9B-4E6BAF2ACC7EQ36036346-E07F7D38-B826-4CF6-B4E4-35D317ED2CF9Q36295174-08D1DAB5-523E-437D-9AD5-C1D7E7463A1DQ36715531-5408C9B5-2A7A-4147-BDDA-BF3DF1BFAD5EQ36746512-A3820996-249D-4DCC-AAC3-97DB2B425937Q36902123-455BD274-FE14-4605-916B-A315C9007E82Q36905573-F50D9CFB-1AF1-4419-968B-06BCEE9D06E3Q36915150-04BF310C-C580-40F5-9377-7D518DBF2C30Q37124538-3E27B21B-16ED-4BB3-BEF4-E176252A066BQ37216236-8DA21C9C-2EF3-4C44-AFFF-5C3E7279DFC2Q37263182-7FBB487F-9680-427E-BA59-77CFAA420D67Q37443125-6191E090-8C2A-4193-8654-83240A1BCFDFQ37566693-7E9F218B-A2F1-4104-B7C2-5206BA996DEFQ37998567-673D10B8-EB7C-48D5-A577-01FF83B9E1F5Q38013047-CCD2C9D6-ABA8-4965-92A6-E10838820B1AQ38142167-F1DDF439-AA87-4F58-910C-3C2A40521FE4Q38194133-3E356AEE-F567-4710-93DF-B4013A374097Q38248521-AB9F2AE7-E653-4171-AD30-C3C670C9E19EQ38350274-A366978F-C089-4C31-A03F-78D70983EA75Q38366376-978661A6-C1A4-4ED3-BA53-88C9B5C3F18BQ38747929-F9D1BC1B-630E-42CA-ABAD-6F4C93949E2FQ38841732-82B200AE-0449-47F0-ADEB-2C7C307AF7A7Q38917137-A354580C-78A4-4F97-AB38-9BC857B4F000Q39176779-DCC5E6A0-311E-44FD-BF83-765748956875Q39305147-2ED64653-6EB5-4AE6-BB48-05BFF33F8F29Q39605721-86B5B550-B584-4A2E-AD4C-EF8608FD1C7CQ40849677-39D379E2-E9A8-4EA9-A371-7C5AEFCBB1E2Q40859434-C4AB0CDF-F2AF-443E-8E68-5D7BB3A33AABQ41411372-AC40176F-545F-4E9E-A331-B17DC7292063Q41478754-908E901A-1257-446D-ABE1-8BB34D930F57
P2860
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@ast
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@en
type
label
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@ast
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@en
prefLabel
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@ast
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@en
P2093
P2860
P1433
P1476
Reduced-intensity conditioning ...... GVHD, and durable remissions.
@en
P2093
Amittha Wickrema
Andrew S Artz
Elizabeth S Rich
Hongtao Liu
John Cunningham
Justin Kline
Linda Schroeder
Loren Joseph
Lucy Godley
P2860
P304
P356
10.1182/BLOOD-2011-08-372508
P407
P577
2011-10-05T00:00:00Z